GSDMD and metabolic dysfunction-associated steatohepatitis: Mechanistically, GSDMD activity contributes to NASH progression by promoting pore formation, and the subsequent cytokine secretion from liver (e.g. IL-1β, TNF-α, and MCP-1), macrophage infiltration, and persistent activation of NF-κB signaling pathway (84).